DOI: http://dx.doi.org/10.18203/2349-2902.isj20164417

Prevalence of cerebro-vascular disease in patients of peripheral arterial occlusive disease

Sandeep Mahapatra, Pinjala Ramakrishna, G. V. Praveen Kumar

Abstract


Background:Peripheral arterial occlusive disease (PAOD) is a surrogate marker of systemic atherosclerosis which also predicts the risk of cerebro-vascular disease (CVD).

Methods: We have conducted a prospective study in 100 symptomatic PAOD patients between 18 to 65 years of age for detection of CVD over a period of two years. Segmental blood pressure and pulse volume recording, Duplex ultrasound blood flow of the peripheral arterial system and carotid arteries were done along with evaluation for risk factors of atherosclerosis i.e., hypertension, diabetes mellitus, hyperlipidemia, smoking history.

Results:Mean age 51.83±13.17 with history of smoking (68%), followed by diabetes (57%), dyslipidemia (29%) and hypertension in (23%) of patients.78% of the patients had PAOD in lower limbs. Overall, 30% of the patients had carotid artery stenosis, out of which 17% had less than 50% stenosis of the carotid artery and 13%had greater than 50% stenosis of the carotid artery. 30.8% of patients with lower limb disease and 60% of the patients with aorto-iliac disease had carotid artery disease.

Conclusions:This association of PAOD with CVD is significant, indicating regular screening in patients of athererosclerotic PAOD .This is further increased with age, and the presence of hypertension and smoking. We could not establish any association with diabetes, dyslipidemia in the prevalence of CVD in our subset of patients with PAOD.


Keywords


CVD, Carotid artery, Duplex scan, PAOD

Full Text:

PDF

References


Clement DL, Boccalon A, Dormandy J, Durand Z et al. Clinical approach to the management of patients with coronary and or carotid artery disease who presents with leg ischaemia. Int Angiol. 2000;19:97-125.

Crique MH, Denenberg J. The generalized nature of atheroscherosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med. 1998;3:241-5.

Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nixtro FR, Sheps DS, et al. Association of Ankle – brachial index with coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis. The atherosclerosis risk in communities (ARIC) study. Atherosclerosis. 1997;131:115-25.

Long TH, Criqui MH, Vasileuskis EE, Demenbergjo. The correlation between the severity of peripheral arterial disease and carotid occlusive disease. Vasc Med. 1999:4;135-42.

Chambers BR, Norris JW. Outcome in patients with neck bruits. N Engl J Medicine. 1986;15:605-13.

North American symptomatic carotid endartectomy Trial collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med. 1991;325:445-53.

European carotid surgery trialist’s collaborative group. MRC European carotid surgery trial; interim results for symptomatic patients with severe (70 - 99%) and mild (0 - 29%) carotid stenosis. Lancet. 1991;337:1235-43.

The asymptomatic carotid atheroscterosis study group study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis stroke. 1989;20(7):844-9.

Ahn SS, Baker JD, Walden K, Moore WS. Which asymptomatic patients should undergo routine screening carotid duplex scan. Am J Surg. 1991;162:180-3.

Ramsey DE, Miles RD, Lambeth A. Summer DS. Prevalence of extracranial carotid artery disease, a survey of an asymptomatic population with non-invasive technique. J Vasc Surg. 1987;5:584-8.

Kaneel WB, Gee DL. Update on some epidemiologic features of intermittent claudication the Framingham study. J AM Geriatr Soc. 1985;33:13-8.

Gill HC, Herderick EE, Mohan CA. Atherosclerosis in youth. Minerva Pediatr. 2002;4:427.

Wolfe PA, Kannel WB, Verter J. Epidemiologic appraisal of hypertensive and stroke risk in Guthrie GP Jr,Kotchen ta (eds): Hypertension and brain Mt Kisco NYF ultra publishing.1984:221.

Leng GC, Papacosta O, Whincup P. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000;152:167-74.

Kannel WB, Shurtleff D. National heart and lunch study: cigarettes and the development of intermittent claudication. Geriatrics. 1992:61-8.

Kannel WB, Gee DL. Update on some epidemiologic features of intermittent claudication: the Framingham study. J Am Geriatric. 1985;33:13-8.

Kannel WB, Agostino RB, Wilson PW. Diabetes fibrinogen and risk of cardiovascular disease: the Framingham experience: Am Heart. 1990;120:672-6.

Safar ME, Larvent S, Asmar EE. Systolic hypertension in patients with arthersclerosis obliterans of lower limb. Angiology. 1987;38:287-95.

The sixth report of the joint national committee on prevention, detection, Evaluation and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46.

Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (45) lancet 1994;344:1383-9.

Texon M. The hemodynamic basis of atherosclerosis further observations: The linear lesion (erratum in bull NY Acad med 62: 1048, 1986). Bull NY Acad Med. 1986;62:875-7.

Glagov S, Rowley DA, Kohut R. Atherosclerosis of human aorta and its coronary and renal arteries Arch Pathol Lab Med. 1961;72:558-63.

Sbergen RJ, Ravensbergen JW, Krijger JK. Localizing role of hemodynamic in atherosclerosis in several human vertebrobasilar junction geometries. Arterioscler Thromb Vasc. 1998;18:693-6.

Giddens DP, Zarins CK. Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque location and low and oscillating shear stress. Arteriosclerosis. 1985;5:293.

Wolinsky H, Glagov S. Comparison of abdominal and thoracic aorta medial structure in mammals: deviation from usual pattern in man. Circ Res. 1967;25:633.

Gordon T, Kannel WB. Predis position of atherosclerosis in the head, heart and legs: The Framingham study, JAMA. 1972;221:661.

Balaj MR, Deewe S. Auductor canal outlet syndrome. JAMA. 1981;245:167-9.

Carter SA. Indirect systolic pressure and pulse waves in arterial occlusive disease of lower extremities. Circulation. 1968;37:624-9.

Curter SA. Clinical measurement of systolic pressure in limbs with arterial occlusive disease JAMA. 1969;207:1869.

Berkowitz HD, Bobb CL, Roberts B. Valve of routine vascular laboratory studies to identify vein graft stenosis. Surgery. 1981;90:971.

Skinner JS, Strandness DE. Exercise and intermittent claudicaion: effect of repetition and intensity of exercise. Circulation. 1967;36:15.

Shakiba M, Soori H, Mansournia MA, Nazari SS, Salimi Y. Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study. Epidemiol Health. 2016;38:2016025.

Rutherford RB, Lowenstein DM, Klein MF. Combining segmental systolic pressure and phethysmography to diagnose arterial occlusive disease of the legs. Amj Surg. 1979;138:211.

Darling RC, Rarnes JK, Brener BJ. Quantitative segmental pulse volume recorder, a clinical tool. Surgery. 1972;72:873.

Roederrer G, Langloisye, Chan A. Ultrasonic duplex scanning of extra cranial carotid arteries: Improved accuracy using new features from the common carotid artery. J Cardlovasa Ultrasonography. 1982;1:373-80.

Grant EG, Benson CB, Moneta G L. Carotid artery stenosis: gray - scale and Doppler US diagnosis society of Radiologist in ultrasound consensus conference. Radiology. 2003;229:340-6.

House AK, Bell R, House J, Mastaglia F, Kumar A, Antuono M. Asymptomatic carotid artery stenosis associated with peripheral vascular disease: a prospective study. Cardiovasc Surg. 1999;7(1):44-9.

Klop RB, Eikelboom BC, Taks AC. Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg. 1991;5(1):41-5.

Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26.